BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24684857)

  • 1. A multicentric evaluation of the recombinant Leishmania infantum antigen-based immunochromatographic assay for the serodiagnosis of canine visceral leishmaniasis.
    Fraga DB; da Silva ED; Pacheco LV; Borja LS; de Oliveira IQ; Coura-Vital W; Monteiro GR; Oliveira GG; Jerônimo SM; Reis AB; Veras PS
    Parasit Vectors; 2014 Mar; 7():136. PubMed ID: 24684857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an ELISA for canine leishmaniasis immunodiagnostic using recombinant proteins.
    de Souza CM; Silva ED; Ano Bom AP; Bastos RC; Nascimento HJ; da Silva Junior JG
    Parasite Immunol; 2012 Jan; 34(1):1-7. PubMed ID: 21929686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection and persistent positivity of anti-Leishmania antibodies using a recombinant protein-based ELISA in naturally infected dogs in Brazil.
    de Jesus MS; Cruz JVA; Coelho LB; Borja LS; da Silva ED; Solcà MDS; Brodskyn CI; Fraga DBM
    Parasit Vectors; 2021 Aug; 14(1):398. PubMed ID: 34384487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex flow cytometry serology to diagnosis of canine visceral leishmaniasis.
    Ker HG; Coura-Vital W; Valadares DG; Aguiar-Soares RDO; de Brito RCF; Veras PST; Fraga DBM; Martins-Filho OA; Teixeira-Carvalho A; Reis AB
    Appl Microbiol Biotechnol; 2019 Oct; 103(19):8179-8190. PubMed ID: 31388731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the DPP(®) CVL rapid test for canine serodiagnosis in area of visceral leishmaniasis.
    Laurenti MD; de Santana Leandro MV; Tomokane TY; De Lucca HR; Aschar M; Souza CS; Silva RM; Marcondes M; da Matta VL
    Vet Parasitol; 2014 Oct; 205(3-4):444-50. PubMed ID: 25257505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.
    Larson M; Toepp A; Scott B; ; Kurtz M; Fowler H; Esfandiari J; Howard RF; Vallur AC; Duthie MS; Petersen C
    Appl Microbiol Biotechnol; 2017 Jan; 101(1):381-390. PubMed ID: 27796441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Performance of ELISA test using recombinant rLiNTPDase2 from Leishmania infantum: a Phase II diagnosis of Canine Visceral Leishmaniasis.
    de Souza ACA; Castro RB; Dos Santos YL; Pavione NDRT; Agripino JM; Bahia MT; Machado-Coelho GLL; de Souza RF; de Oliveira LL; Souza CDSF; Bressan GC; Vasconcellos RS; de Almeida MR; Fietto JLR
    Acta Trop; 2020 Sep; 209():105535. PubMed ID: 32450137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of three recombinant proteins for the development of ELISA and immunochromatographic tests for visceral leishmaniasis serodiagnosis.
    Santos ARRD; Serufo ÂV; Figueiredo MM; Godoi LC; Vitório JG; Marcelino AP; Avelar DM; Rodrigues FTG; Machado-Coelho GLL; Medeiros FAC; Jerônimo SMB; Oliveira EJ; Nascimento FC; Teixeira SMR; Gazzinelli RT; Nagem RAP; Fernandes AP
    Mem Inst Oswaldo Cruz; 2019 Feb; 114():e180405. PubMed ID: 30726344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of three recombinant Leishmania infantum antigens in human and canine visceral leishmaniasis diagnosis.
    Fonseca AM; Faria AR; Rodrigues FT; Nagem RA; Magalhães RD; Cunha JL; Bartholomeu DC; de Andrade HM
    Acta Trop; 2014 Sep; 137():25-30. PubMed ID: 24801885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.
    Costa LE; Lima MI; Chávez-Fumagalli MA; Menezes-Souza D; Martins VT; Duarte MC; Lage PS; Lopes EG; Lage DP; Ribeiro TG; Andrade PH; de Magalhães-Soares DF; Soto M; Tavares CA; Goulart LR; Coelho EA
    Clin Vaccine Immunol; 2014 Jan; 21(1):96-106. PubMed ID: 24256622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-antigen print immunoassay (MAPIA)-based evaluation of novel recombinant Leishmania infantum antigens for the serodiagnosis of canine visceral leishmaniasis.
    de Oliveira IQ; Silva RA; Sucupira MV; da Silva ED; Reis AB; Grimaldi G; Fraga DB; Veras PS
    Parasit Vectors; 2015 Jan; 8():45. PubMed ID: 25616448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Rapid Test Based on Leishmania infantum Chimeric rK28 Protein Improves the Diagnosis of Canine Visceral Leishmaniasis by Reducing the Detection of False-Positive Dogs.
    Fraga DB; Pacheco LV; Borja LS; Tuy PG; Bastos LA; Solcà Mda S; Amorim LD; Veras PS
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004333. PubMed ID: 26731098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of human and canine visceral leishmaniasis: assessment of a latex agglutination test based on the A2 antigen from amastigote forms of Leishmania infantum.
    Akhoundi B; Mohebali M; Shojaee S; Jalali M; Kazemi B; Bandehpour M; Keshavarz H; Edrissian GH; Eslami MB; Malekafzali H; Kouchaki A
    Exp Parasitol; 2013 Mar; 133(3):307-13. PubMed ID: 23276878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Dual-path Platform chromatographic immunoassay (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis.
    Figueiredo FB; Vasconcelos TCB; Madeira MF; Menezes RC; Maia-Elkhoury ANS; Marcelino AP; Werneck GL
    Mem Inst Oswaldo Cruz; 2018 Nov; 113(11):e180260. PubMed ID: 30379198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High accuracy of an ELISA test based in a flagella antigen of Leishmania in serodiagnosis of canine visceral leishmaniasis with potential to improve the control measures in Brazil - A Phase II study.
    Borja LS; Coelho LB; Jesus MS; de Queiroz ATL; Celedon PAF; Zanchin NIT; Silva ED; Ferreira AGP; Krieger MA; Veras PST; Fraga DBM
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006871. PubMed ID: 30365504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Immunological Assays Based on
    Ejazi SA; Saha S; Bhattacharyya A; Das S; Mateus NLF; da Costa Lima MS; Neitzke-Abreu HC; de Mendonca IL; Costa CHN; de Oliveira Melo OA; de Melo MA; Rossi-Bergmann B; Corso R; Manna L; Ali N
    Front Cell Infect Microbiol; 2022; 12():914477. PubMed ID: 35846748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a prototype flow cytometry test for serodiagnosis of canine visceral leishmaniasis.
    Ker HG; Coura-Vital W; Aguiar-Soares RD; Roatt BM; das Dores Moreira N; Carneiro CM; Machado EM; Teixeira-Carvalho A; Martins-Filho OA; Giunchetti RC; Araújo MS; Coelho EA; da Silveira-Lemos D; Reis AB
    Clin Vaccine Immunol; 2013 Dec; 20(12):1792-8. PubMed ID: 24108778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a novel chromatographic immunoassay based on Dual-Path Platform technology (DPP® CVL rapid test) for the serodiagnosis of canine visceral leishmaniasis.
    Grimaldi G; Teva A; Ferreira AL; dos Santos CB; Pinto Id; de-Azevedo CT; Falqueto A
    Trans R Soc Trop Med Hyg; 2012 Jan; 106(1):54-9. PubMed ID: 22137538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts.
    Coelho EA; Ramírez L; Costa MA; Coelho VT; Martins VT; Chávez-Fumagalli MA; Oliveira DM; Tavares CA; Bonay P; Nieto CG; Abánades DR; Alonso C; Soto M
    Clin Vaccine Immunol; 2009 Dec; 16(12):1774-80. PubMed ID: 19812259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.